307 related articles for article (PubMed ID: 11810193)
41. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
[TBL] [Abstract][Full Text] [Related]
42. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
[TBL] [Abstract][Full Text] [Related]
43. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
[TBL] [Abstract][Full Text] [Related]
44. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases.
Kovacs GG; Voigtländer T; Hainfellner JA; Budka H
Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919
[TBL] [Abstract][Full Text] [Related]
45. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
Nailon WH; Ironside JW
Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
[TBL] [Abstract][Full Text] [Related]
46. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
47. A special report I. Prion protein (PrP)--amyloid plaques in the transmissible spongiform encephalopathies, or prion diseases revisited.
Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
Folia Neuropathol; 2001; 39(4):217-35. PubMed ID: 11928893
[TBL] [Abstract][Full Text] [Related]
48. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.
Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical investigations of the prion protein accumulation in human spongiform encephalopathies. Special report II.
Zaborowski A; Kordek R; Botts GT; Liberski PP
Pol J Pathol; 2003; 54(1):39-47. PubMed ID: 12817879
[TBL] [Abstract][Full Text] [Related]
50. Sensitive detection of PrPSc by Western blot assay based on streptomycin sulphate precipitation.
Dong CF; Huang YX; An R; Chen JM; Wang XF; Shan B; Lei YJ; Han L; Zhang BY; Han J; Dong XP
Zoonoses Public Health; 2007; 54(8):328-36. PubMed ID: 17894644
[TBL] [Abstract][Full Text] [Related]
51. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
52. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
53. Creutzfeldt-Jakob disease with Alzheimer-type A beta-reactive amyloid plaques.
Barcikowska M; Kwiecinski H; Liberski PP; Kowalski J; Brown P; Gajdusek DC
Histopathology; 1995 May; 26(5):445-50. PubMed ID: 7657313
[TBL] [Abstract][Full Text] [Related]
54. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques.
Kitamoto T; Iizuka R; Tateishi J
Biochem Biophys Res Commun; 1993 Apr; 192(2):525-31. PubMed ID: 8097911
[TBL] [Abstract][Full Text] [Related]
55. Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred).
Piccardo P; Seiler C; Dlouhy SR; Young K; Farlow MR; Prelli F; Frangione B; Bugiani O; Tagliavini F; Ghetti B
J Neuropathol Exp Neurol; 1996 Nov; 55(11):1157-63. PubMed ID: 8939199
[TBL] [Abstract][Full Text] [Related]
56. Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting.
Kuczius T; Brinkmann B; Grassi J
Neurochem Int; 2007 Jan; 50(1):102-8. PubMed ID: 16962685
[TBL] [Abstract][Full Text] [Related]
57. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
58. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases.
Liberski PP; Sikorska B; Hauw JJ; Kopp N; Streichenberger N; Giraud P; Budka H; Boellaard JW; Brown P
Virus Res; 2008 Mar; 132(1-2):226-8. PubMed ID: 18164506
[TBL] [Abstract][Full Text] [Related]
59. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
[TBL] [Abstract][Full Text] [Related]
60. Prion protein glycosylation.
Lawson VA; Collins SJ; Masters CL; Hill AF
J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
